Board of Directors

Dr. Ashleys is in the process of appointing a seven-member Board of Directors. The majority of these members will be independent, bringing a wealth of expertise in the medical field, legal and regulatory compliance, global business strategy, and pharmaceutical industry leadership. Upon their election at the forthcoming shareholder meeting, the names of the newly appointed board members will be published here.